Meriam DEXHEIMER Email
Technicienne de production de vecteurs viraux grade R&D . Flash Therapeutics
Toulouse,
LocationM***************@flashtherapeutics.com
Primary EmailHow to contact Meriam DEXHEIMER
Join and see Meriam's contact info for free!Current Roles
Employees:
73Revenue:
$11.3MAbout
Flash Therapeutics is a new gene therapy company developing gene and cell-based therapies by leveraging its proprietary lentiviral platform and bioproduction technologies. The Company is built around the Vectalys lentiviral platform, which includes its patented non-integrative LentiFlash® technology, and integrative lentiviral vectors. By providing efficient, transient and short-term RNA delivery technology, LentiFlash® is suitable for gene editing and other advanced therapeutic approaches. When stable DNA expression is needed (e.g. immunotherapy such as CAR T cells), integrative lentiviral vectors will be the delivery method of choice. Both technologies benefit from novel production and purification processes developed and continually optimized since 2005. Flash Therapeutics is advancing two business lines: - Therapeutic development based on LentiFlash®, with internal programs for blood and liver diseases; - Development and manufacturing support to companies worldwide pursuing lentiviral delivered therapies. Flash Therapeutics was established in 2018 through the merger of FlashCell, a privately held company developing LentiFlash®, based RNA therapeutics; and Vectalys, a leading privately held 13-year old lentiviral vector manufacturer.Flash Therapeutics Address
3, Avenue Hubert CurienToulouse, null